Features of the course of coronary artery disease in the post-COVID period
https://doi.org/10.31549/2542-1174-2023-7-1-18-30
Abstract
Introduction. The coronavirus disease 2019 (COVID-19) pandemic has been going on for more than two years and is significantly affecting routine clinical practice. Despite the numerous publications on heart damage in the acute phase of COVID-19, there is not enough data regarding the dynamics of cardiovascular system condition in coronary artery disease (CAD) patients after the infection caused by SARS-CoV-2. The influence of the long-term consequences of the disease on cardiovascular system condition of patients who have had infection requires careful study.
Aim. To assess the clinical and laboratory picture and coronary lesion nature in CAD patients with mild or moderate course of COVID-19 infection after at least 12 weeks.
Materials and methods. The analysis of clinical, laboratory parameters and coronary angiography of 118 CAD patients aged 46–67 years (mean age 60.2 ± 6.1 years) after a serologically confirmed SARS-CoV-2 infection at the lapse of 12 weeks was carried out. The patients were divided into 2 groups: group 1 included 60 patients with a mild COVID-19, group 2 included 58 patients with a moderate COVID-19 course.
Results. CAD patients with a moderate course of COVID-19 in the acute period had higher values of office blood pressure, higher incidence of uncontrolled arterial hypertension, major multivessel lesions of coronary arteries and lesions of the main vessels than CAD patients with mild COVID-19. When comparing echocardiographic parameters in patients with moderate COVID-19, the lower parameters of the left ventricular ejection fraction were found which is quite consistent with the higher NT-proBNP values in these patients.
Conclusion. CAD patients, who have had moderate COVID-19 in the acute phase of infectious process, constitute a special risk group for a subsequent more severe course of the underlying disease.
About the Authors
D. A. Derisheva
Novosibirsk State Medical University
Russian Federation
Russian Federation
Daria A. Derisheva – Cand. Sci. (Med.), Assistant, Department of Pharmacology, Clinical Pharmacology and Evidence-Based Medicine
52, Krasny prosp., Novosibirsk, 630091
D. A. Yakhontov
Novosibirsk State Medical University
Russian Federation
Russian Federation
Davyd A. Yakhontov – Dr. Sci. (Med.), Professor, Department of Pharmacology, Clinical Pharmacology and Evidence-Based Medicine
Novosibirsk
O. V. Dunicheva
Novosibirsk Regional Clinical Cardiology Dispensary
Russian Federation
Russian Federation
Oksana V. Dunicheva – Cand. Sci. (Med.), Chief Physician
Novosibirsk
References
1. Larina V.N., Golovko M.G., Larin V.G. Possible effects of coronavirus infection (COVID-19) on the cardiovascular system. Bulletin of Russian State Medical University. 2020;2:5-13. DOI: 10.24075/brsmu.2020.020. (In Russ.)
2. Bubnova M.G., Persiyanova-Dubrova A.L., Lyamina N.P., Aronov D.M. Rehabilitation after new coronavirus infection (COVID-19): principles and approaches. CardioSomatics. 2020;11(4):6-14. DOI: 10.26442/22217185.2020.4.200570. (In Russ.)
3. Vorobiev P.A. (ed.) (2021). Guidelines for the management of patients with coronavirus infection (COVID-19) in the acute phase and with post-covid syndrome on an outpatient basis. URL: https://guidelines.mgnot.ru/v2_2021 (accessed 29.11.2022).
4. Features of the course of long-COVID. Treatment and rehabilitation. Guidelines (approved at the XVI National Congress of Therapists, 18.11.2021). URL: https://irk-gb6.ru/images/uploads/c0c122cdc473c3b9968cce024a0ccdac.pdf (accessed 29.11.2022).
5. Michelen M., Manoharan L., Elkheir N. et al. Characterising long COVID: a living systematic review. BMJ Global Health. 2021;6(9):e005427. DOI: 10.1136/bmjgh-2021-005427.
6. World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. 6 October 2021. URL: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (accessed 29.11.2022).
7. Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G. et al. Clinical features of post-COVID-19 period. Results of the International register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2).” Data from 6-month follow-up. Russian Journal of Cardiology. 2021;26(10):4708. DOI: 10.15829/1560-4071-2021-4708. (In Russ.)
8. Polyakova O.A., Ostroumova O.D., Mironova E.V. et al. Prospects for the use of a fixed combination of bisoprolol and amlodipine in the treatment of patients with post-COVID syndrome. Medical Council. 2021;(14):23-34. DOI: 10.21518/2079-701X-2021-14-23-34. (In Russ.)
9. Tarlovskaya E.I., Arutyunov A.G., Konradi A.D. et al. Analysis of infl uence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIVE SARS-CoV-2 registry (“Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2”). Kardiologiia. 2021;61(9):20-32. DOI: 10.18087/cardio.2021.9.n1680. (In Russ.)
10. Ayoubkhani D., Khunti K., Nafi lyan V. et al. Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. medRχiv. 2021. DOI: 10.1101/2021.01.15.21249885.
11. Cabrera Martimbianco A.L., Pacheco R.L., Bagattini Â.M., Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int. J. Clin. Pract. 2021;75(10):e14357. DOI: 10.1111/ijcp.14357.
12. Karpov Yu.A., Komissarenko I.A. Cardiovascular system damage in SARS-CoV-2 infection. Role of β-blockers and calcium channel blockers. Atmosphere. Cardiology News. 2020;4:3-11. DOI: 10.24412/2076-4189-2020-12313. (In Russ.)
13. Kunal S., Madan M., Tarke C. et al. Emerging spectrum of post-COVID-19 syndrome. Postgrad. Med. J. 2022;98(1162):633-643. DOI: 10.1136/postgradmedj-2020-139585.
14. Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18(4):844-847.
15. Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53(10):737-754. DOI: 10.1080/23744235.2021.1924397.
16. Prevention, diagnosis and treatment of a novel coronavirus infection (COVID-19). Temporary guidelines. Version 15 (22.02.2022). URL: nasci.ru/?id-697688download-1 (accessed 27.12.2022).
Review
For citations:
Derisheva D.A., Yakhontov D.A., Dunicheva O.V. Features of the course of coronary artery disease in the post-COVID period. Journal of Siberian Medical Sciences. 2023;(1):18-30. https://doi.org/10.31549/2542-1174-2023-7-1-18-30
Views:
331
Email this article 